Subsequently, we found that in CESC, HNSC, SKCM, and UCEC, patients with high SASH3 levels had longer PFS, and in ESCC and LGG, patients with low SASH3 levels had longer PFS (Figures 4A, B). This evidence concerns the gene SASH3 and esophageal squamous cell carcinoma.